FDA EUA approval

Moderna to seek FDA authorization for lower-dose Covid-19 vaccine for children under 6

The following is an excerpt from MedPage. Moderna’s two-dose Covid-19 vaccine regimen for the youngest children was safe and met its primary immunogenicity endpoint, the manufacturer announced on Wednesday. An interim analysis of the phase II/III KidCOVE study found that two

Moderna to seek FDA authorization for lower-dose Covid-19 vaccine for children under 6 Read More »

Scroll to Top